Literature DB >> 12799421

The ectodomain shedding of angiotensin-converting enzyme is independent of its localisation in lipid rafts.

Edward T Parkin1, Fulong Tan, Randal A Skidgel, Anthony J Turner, Nigel M Hooper.   

Abstract

Angiotensin-converting enzyme (ACE), a type I integral membrane protein that plays a major role in vasoactive peptide metabolism, is shed from the plasma membrane by proteolytic cleavage within the juxtamembrane stalk. To investigate whether this shedding is regulated by lateral segregation in cholesterol-rich lipid rafts, Chinese hamster ovary cells and human neuroblastoma SH-SY5Y cells were transfected with either wild-type ACE (WT-ACE) or a construct with a glycosylphosphatidylinositol (GPI) anchor attachment signal replacing the transmembrane and cytosolic domains (GPI-ACE). In both cell types, GPI-ACE, but not WT-ACE, was sequestered in caveolin or flotillin-enriched lipid rafts and was released from the cell surface by treatment with phosphatidylinositol-specific phospholipase C. When cells were treated with activators of the protein kinase C signalling cascade (phorbol myristate acetate or carbachol) the shedding of GPI-ACE was stimulated to a similar extent to that of WT-ACE. The release of WT-ACE and GPI-ACE from the cells was inhibited in an identical manner by a range of hydroxamate-based zinc metalloprotease inhibitors. Disruption of lipid rafts by filipin treatment did not alter the shedding of GPI-ACE, and phorbol ester treatment did not alter the distribution of WT-ACE or GPI-ACE between raft and non-raft membrane compartments. These data clearly show that the protein kinase C-stimulated shedding of ACE does not require the transmembrane or cytosolic regions of the protein, and that sequestration in lipid rafts does not regulate the shedding of the protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799421     DOI: 10.1242/jcs.00626

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  6 in total

1.  Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.

Authors:  David R Taylor; Edward T Parkin; Sarah L Cocklin; James R Ault; Alison E Ashcroft; Anthony J Turner; Nigel M Hooper
Journal:  J Biol Chem       Date:  2009-06-29       Impact factor: 5.157

2.  A small region in the angiotensin-converting enzyme distal ectodomain is required for cleavage-secretion of the protein at the plasma membrane.

Authors:  Saurabh Chattopadhyay; Goutam Karan; Indira Sen; Ganes C Sen
Journal:  Biochemistry       Date:  2008-07-18       Impact factor: 3.162

Review 3.  Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease.

Authors:  Ling Zhang; Rolf Postina; Yingqun Wang
Journal:  Cell Mol Life Sci       Date:  2009-12       Impact factor: 9.261

4.  Antenatal betamethasone exposure is associated with lower ANG-(1-7) and increased ACE in the CSF of adult sheep.

Authors:  Allyson C Marshall; Hossam A Shaltout; Nancy T Pirro; James C Rose; Debra I Diz; Mark C Chappell
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-08-15       Impact factor: 3.619

5.  Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling.

Authors:  David A Hicks; Natalia N Nalivaeva; Anthony J Turner
Journal:  Front Physiol       Date:  2012-06-22       Impact factor: 4.566

6.  Lipid rafts: linking prion protein to zinc transport and amyloid-β toxicity in Alzheimer's disease.

Authors:  Nicole T Watt; Heledd H Griffiths; Nigel M Hooper
Journal:  Front Cell Dev Biol       Date:  2014-08-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.